BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen J, Lu Z, Wang J, Zhang T, Yang J, Li Y, Liu G, Zhang X. Advances of Nanoparticles for Leukemia Treatment. ACS Biomater Sci Eng 2020;6:6478-89. [PMID: 33320613 DOI: 10.1021/acsbiomaterials.0c01040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Ahmad A, Gulraiz Y, Ilyas S, Bashir S. Polysaccharide based nano materials: Health implications. Food Hydrocolloids for Health 2022;2:100075. [DOI: 10.1016/j.fhfh.2022.100075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kamel R, Abousamra MM, Afifi SM, Galal AF. Phyto-emulsomes as a novel nano-carrier for morine hydrate to combat leukemia: In vitro and pharmacokinetic study. Journal of Drug Delivery Science and Technology 2022;75:103700. [DOI: 10.1016/j.jddst.2022.103700] [Reference Citation Analysis]
3 Konhäuser M, Kannaujiya VK, Steiert E, Schwickert K, Schirmeister T, Wich PR. Co-Encapsulation of l-Asparaginase and Etoposide in Dextran Nanoparticles for Synergistic Effect in Chronic Myeloid Leukemia Cells. Int J Pharm 2022;:121796. [PMID: 35525474 DOI: 10.1016/j.ijpharm.2022.121796] [Reference Citation Analysis]
4 Zoulikha M, He W. Targeted Drug Delivery for Chronic Lymphocytic Leukemia. Pharm Res. [DOI: 10.1007/s11095-022-03214-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Young SAE, Muthami J, Pitcher M, Antovski P, Wamea P, Murphy RD, Haghniaz R, Schmidt A, Clark S, Khademhosseini A, Sheikhi A. Engineering hairy cellulose nanocrystals for chemotherapy drug capture. Mater Today Chem 2022;23:100711. [PMID: 35224320 DOI: 10.1016/j.mtchem.2021.100711] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zeng Y, Xiang Y, Sheng R, Tomás H, Rodrigues J, Gu Z, Zhang H, Gong Q, Luo K. Polysaccharide-based nanomedicines for cancer immunotherapy: A review. Bioactive Materials 2021;6:3358-82. [DOI: 10.1016/j.bioactmat.2021.03.008] [Reference Citation Analysis]
7 Zeng Y, Xiang Y, Sheng R, Tomás H, Rodrigues J, Gu Z, Zhang H, Gong Q, Luo K. Polysaccharide-based nanomedicines for cancer immunotherapy: A review. Bioact Mater 2021;6:3358-82. [PMID: 33817416 DOI: 10.1016/j.bioactmat.2021.03.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 28.0] [Reference Citation Analysis]